
Antiobesity Medications: Expert Compares Benefits, Drawback Among Classes
Obesity specialist Sandra Christensen, MSN, ARNP, compares the benefits and drawbacks among older antiobesity drugs and newer GLP-1RAs liraglutide and semaglutide 2.4 mg.
In a recent interview with Patient Care Online, medical weight management specialist Sandra Christensen, MSN, ARNP, was asked the following question:
Ms Christensen discusses how the different classes of antiobesity medications compare in cost, side effect profiles, and more in the video below.
For a primer on common antiobesity medications, check out part 1 of our interview with Ms Christensen:
Sandra Christensen, MSN, ARNP, is the owner of
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.












































































































